Metraipolis › archive › dc_7cf8be114588

mTOR inhibition augments antitumor immune effector response by reprogramming the TP53-mutant, immune-cold HNSCC tumor microenvironment — Europe PMC PMID:42570420

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42570420
DOI
10.1016/j.neo.2026.101350
License (as archived)
solo-consultazione
Archived
2026-10-16T22:51:43.557Z
SHA-256 of the archived text
64847c801748d663294a12318063b33d741745d73076059b2cc2413b136dcb5f
Stable URL of this page
https://metraipolis.com/documento/dc_7cf8be114588

How to cite

mTOR inhibition augments antitumor immune effector response by reprogramming the TP53-mutant, immune-cold HNSCC tumor microenvironment — Europe PMC PMID:42570420 — Europe PMC (en), https://europepmc.org/article/MED/42570420 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7cf8be114588 (Metraipolis archive dc_7cf8be114588, sha256 64847c801748d663294a12318063b33d741745d73076059b2cc2413b136dcb5f)
BibTeX
@misc{dc7cf8be114588,
  title = {mTOR inhibition augments antitumor immune effector response by reprogramming the TP53-mutant, immune-cold HNSCC tumor microenvironment — Europe PMC PMID:42570420},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42570420},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7cf8be114588; sha256 64847c801748d663294a12318063b33d741745d73076059b2cc2413b136dcb5f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42570420. Agents can read the archived copy with the MCP tool read_document.